Physician profile
Laura Macke
NPI 1174194369
$2,027.11
in general payments reported to CMS, 2019-2025
17 companies · $1,636 in 2025
The $1,636 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $391 · 2025: $1,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,008 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,008.11 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $322.08 | 2024-2025 | Azstarys |
| Abbvie INC. | $318.77 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $243.53 | 2024-2025 | Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $226.89 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $157.20 | 2024-2025 | Spravato, Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $139.43 | 2025 | Caplyta |
| Noven Therapeutics, LLC | $128.25 | 2024-2025 | Xelstrym, Secuado |
| Tris Pharma INC | $71.57 | 2025 | Dyanavel Xr |
| Vanda Pharmaceuticals INC. | $68.24 | 2025 | Fanapt |
| Axsome Therapeutics, INC. | $60.34 | 2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $59.38 | 2024 | Quviviq |
| Lundbeck LLC | $55.78 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $55.29 | 2025 | Cobenfy |
| Alkermes, INC. | $38.12 | 2025 | Aristada, Lybalvi, Vivitrol |
| Neurocrine Biosciences, INC. | $33.71 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $29.53 | 2025 | Trintellix |
| Intuitive Surgical, INC. | $19.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Macke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.